Galectin Therapeutics Inc.

This study looks at how the drug belapectin moves through the body in people with mild, moderate, or severe liver impairment compared to healthy volunteers. Participants receive a single intravenous dose, and researchers measure drug levels in the blood over time. The goal is to …